Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Birth control pills with low-dose estrogen and antiandrogenic progestins can effectively treat acne.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

New compounds may soon be tested to treat excessive hair growth in women.

Hormones, especially testosterone and DHT, are key for penis development and function, and testosterone therapy may help with erectile dysfunction in those with low levels.

Genetic mutations can affect female sexual development, requiring personalized medical care.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

PCOS has many symptoms, with high androgen levels being the most common.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.

Diagnosing Polycystic Ovary Syndrome is hard due to varying symptoms, no set criteria, and the need for better tests and education.

PCOS is a common hormonal disorder with symptoms like irregular periods and excess hair growth, managed with lifestyle changes and medications.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

The document explains that hirsutism, often caused by hormonal issues, can be managed with treatment to improve both physical appearance and mental health.

Skin symptoms often reveal hormonal imbalances in PCOS.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.